Amitabh Chandra is the Malcolm Wiener Professor of Public Policy and Director of Health Policy Research at the Harvard Kennedy School of Government. He is a member of the Congressional Budget Office’s Panel of Health Advisors, and is a Research Associate at the IZA Institute in Bonn, Germany and at the National Bureau of Economic Research. At Harvard, Professor Chandra teaches undergraduates in Harvard College, graduate students at the Kennedy School and Business School, and in Harvard’s Executive Education programs. His research focuses on innovation and cost-growth in health care, medical malpractice, and racial disparities in health care. His research has been supported by the National Institute of Aging, the National Institute of Child Health and Development, and the Robert Wood Johnson Foundation, and has been published in the American Economic Review, the Journal of Political Economy, the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is an editor of the Review of Economics and Statistics, a former editor of the Journal of Human Resources, and serves on the editorial boards of Economics Letters and the American Economic Journal.
Professor Chandra has testified to the United States Senate and the United States Commission on Civil Rights. His research has been featured in The New York Times, The Washington Post, CNN, Newsweek, and on National Public Radio. He has been a consultant to the RAND Corporation, Microsoft Research, the Institute of Medicine and the Blue Cross Blue Shield Foundation of Massachusetts. In 2011 he served as Massachusetts’ Special Commissioner on Provider Price Reform.
Professor Chandra is an elected member of the Institute of Medicine, the first-prize recipient of the Upjohn Institute’s Dissertation Award, the Kenneth Arrow Award for best paper in health economics, and the Eugene Garfield Award for the impact of medical research. In 2012, he was awarded the American Society of Health Economists (ASHE) medal. The ASHE Medal is awarded biennially to the economist age 40 or under who has made the most significant contributions to the field of health economics.